Phronetik®

Phronetik is a Plano, Texas-based biomedical research organization dedicated to advancing precision medicine in research and healthcare. We integrate genomics into research and patient care, conducting our own independent studies and supporting external research initiatives. We leverage AI and advanced genomics to revolutionize inclusive healthcare, offering data-driven insights and personalized treatment options. Our commitment to innovation and patient outcomes is underscored by our partnerships with over 25 businesses and 10 universities, and we hold 3 registered trademarks and 2 proprietary technologies.

Phronetik’s core mission is to unlock new genomic insights, enabling faster and more effective treatment discovery. We specialize in areas such as Oncology, Rare & Complex Disease, Pharmacogenomics, Infectious Disease, and Agrigenomics, providing comprehensive solutions for researchers and healthcare providers.

Through our iConcordia® platform and iHarmony-Seq™ technology, we empower our partners with the tools they need to accelerate drug development, improve patient outcomes, and advance public health initiatives. We are proud to be a key contributor to the future of precision medicine, driving transformative change across the life science and government sectors.